S. Asha Nair

4.9k citations
80 papers · 3.8k indexed · h-index 34
Topics
Nanoplatforms for cancer theranostics (12 papers)NF-κB Signaling Pathways (10 papers)Cancer-related Molecular Pathways (9 papers)
Partner nations
IndiaUnited StatesItaly

In The Last Decade

S. Asha Nair

78 papers receiving 3.7k citations

Peers

S. Asha Nair
Comparison fields: 5 of 130
  • Molecular Biology 2.0k
  • Oncology 891
  • Cancer Research 592
  • Molecular Medicine 409
  • Biomedical Engineering 348
Replace Chanakya Nath Kundu with:
Chanakya Nath Kundu India
Xinbing Sui China
Kiavash Hushmandi Iran
Sang Hun Lee South Korea
Sepideh Mirzaei Iran
Antônio Barbieri Italy
Maliheh Entezari Iran
Nasser Samadi Iran
Min You United States
Jian Luo China
S. Asha Nair relative to Chanakya Nath Kundu India Chanakya Nath Kundu's profile →
Citations per field
00.5×2.6×
Chanakya Nath Kundu · 1×
Citations per year

Countries citing papers authored by S. Asha Nair

Since Specialization
Citations

This map shows the geographic impact of S. Asha Nair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Asha Nair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Asha Nair more than expected).

Fields of papers citing papers by S. Asha Nair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Asha Nair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Asha Nair. The network helps show where S. Asha Nair may publish in the future.

Co-authorship network of co-authors of S. Asha Nair

This figure shows the co-authorship network connecting the top 25 collaborators of S. Asha Nair. A scholar is included among the top collaborators of S. Asha Nair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Asha Nair. S. Asha Nair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 28
5 102
6 11
7 48
8 2
9 22
10 24
11 1
12 76
13 24
14 11
15 196
16 87
17 99
18 190
19 9
20 13

About S. Asha Nair

S. Asha Nair is a scholar working on Cancer Research, Oncology and Physiology, having authored 80 papers that have together received 3.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), NF-κB Signaling Pathways (10 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Molecular Medicine (409 citations), Cancer Research (592 citations) and Toxicology (134 citations). S. Asha Nair has collaborated with scholars based in India, United States and Italy. Frequent co-authors include Bharat B. Aggarwal, M. Radhakrishna Pillai, Gautam Sethi, Devarajan Karunagaran, Ajaikumar B. Kunnumakkara, Anand Krishnan, Sankar Jagadeeshan, Shishir Shishodia, Kwang Seok Ahn and Ruby John Anto. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026